Re: Carlo Andrea Bravi, Sophie Knipper, Axel Heidenreich, et al. Oncologic Outcomes of Template Versus Radioguided Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography Scan: Results from a Multi-institutional Collaboration. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025.05.019.
0/5 보강
APA
Francolini G, Ost P, Zilli T (2025). Re: Carlo Andrea Bravi, Sophie Knipper, Axel Heidenreich, et al. Oncologic Outcomes of Template Versus Radioguided Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography Scan: Results from a Multi-institutional Collaboration. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025.05.019.. European urology focus. https://doi.org/10.1016/j.euf.2025.10.008
MLA
Francolini G, et al.. "Re: Carlo Andrea Bravi, Sophie Knipper, Axel Heidenreich, et al. Oncologic Outcomes of Template Versus Radioguided Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography Scan: Results from a Multi-institutional Collaboration. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025.05.019.." European urology focus, 2025.
PMID
41206242
같은 제1저자의 인용 많은 논문 (3)
- Oncological outcomes after tailored PSMA-PET-guided treatment in biochemical relapse after prostatectomy (PSICHE Trial-NCT 05022914).
- Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry based study on behalf of Italian association of radiotherapy and clinical oncology (AIRO). (RE-START).
- Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719).